Related Experiment Video
Updated: Jun 26, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Contraception in women with special problems]
Alfred Mueck1, Joseph Neulen, Christian Thaler
1Landesinstitut für Frauengesundheit Baden-Württemberg, Universitätsfrauenklinik Tübingen. endo.meno@med.uni-tuebingen.de
Oral contraceptives (OC) do not increase cardiovascular risks in healthy young non-smokers. Genetic predisposition and risk factors are key considerations before prescribing OCs, with regular monitoring advised.
Area of Science:
- Reproductive Health
- Cardiovascular Medicine
- Pharmacology
Context:
- Thromboembolic, cardiovascular, and cerebrovascular events are age-dependent and rare in young women.
- Oral contraceptives (OC) are associated with an increased risk of venous thrombosis, particularly influenced by genetic predisposition.
Purpose:
- To evaluate the risks and benefits of oral contraceptives (OCs) in various patient populations.
- To emphasize the importance of personal and family history in OC prescription.
- To assess the impact of OCs on cardiovascular health, metabolic parameters, and specific medical conditions.
Summary:
- In healthy, non-smoking women under 35, OCs do not elevate the risk of myocardial infarction or cerebrovascular accidents.
- While OCs can rarely increase blood pressure, regular monitoring is recommended. Weight gain is uncommon and individual-dependent.
- OCs have minimal clinical impact on insulin, blood sugar, adrenal, and thyroid function, and do not increase diabetes incidence. Asthma is not a contraindication.
Impact:
- Highlights the safety of OCs in specific low-risk demographics, emphasizing personalized risk assessment.
- Provides guidance on monitoring for potential side effects like hypertension in OC users.
- Suggests potential benefits of OCs in managing cycle-dependent conditions like asthma and specific cases of lupus erythematosus.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Disorders of the Female Reproductive System
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Oral Drug Delivery Systems: Continuous-Release Systems
